6,000
Participants
Start Date
January 18, 2021
Primary Completion Date
July 1, 2025
Study Completion Date
July 1, 2025
Pharmacogenetic Testing
Participants will donate a 2ml (teaspoon) sample of saliva. DNA extracted from the saliva sample will be used for genotyping. Genotyping results will be translated into an interpretative clinical report using evidence-based software (Sequence2Script) developed by our group and delivered to the treating physician for use in their clinical decision-making. The report will contain genotyping results, predicted phenotype, and evidence-based drug selection and dosing recommendations relevant to the child's current and future care
RECRUITING
University of Calgary, Calgary
University of Calgary
OTHER